Literature DB >> 12516540

The TGF-beta response to Leishmania chagasi in the absence of IL-12.

Mary E Wilson1, Thomas J Recker, Nilda E Rodriguez, Betty M Young, Kindra K Burnell, Judy A Streit, Joel N Kline.   

Abstract

Cure of leishmaniasis requires a type 1 immune response characterized by IFN-gamma production. Leishmania major infection leads to a type 2 response suppressing cure of susceptible BALB/c mice, and L. major causes an exacerbated type 2 response in mouse strains with a gene knockout (KO) such that they lack IL-12p40 (IL-12KO mice). In contrast, type 1 responses are inhibited by TGF-beta without Th2 cell expansion in BALB/c mice infected with L. chagasi. We questioned whether the type 2 or the TGF-beta response would dominate during L. chagasi infection of IL-12KO mice. C57BL/6 mice developed self-resolving L. chagasi infection with abundant IFN-gamma. In contrast, L. chagasi disease was exacerbated and IFN-gamma was low in IL-12KO mice. Total TGF-beta was significantly higher in IL-12KO than control C57BL/6 mice, but IL-4 and IL-10 levels were similar. TGF-beta was further augmented in IL-12/IFN-gamma double-KO mice. Thus, in contrast to L. major, the TGF-beta response was exacerbated whereas type 2 cells were not expanded during L. chagasi infection of IL-12KO mice. We conclude that L. chagasi has an inherent propensity to elicit a prominent TGF-beta response that either suppresses, or is suppressed by, a type 1 response. We propose this be termed a "type 3" immune response, which can antagonize a type 1 response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12516540     DOI: 10.1002/1521-4141(200212)32:12<3556::AID-IMMU3556>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Transforming growth factor beta 1 production by CD4+ CD25+ regulatory T cells in peripheral blood mononuclear cells from healthy subjects stimulated with Leishmania guyanensis.

Authors:  A Kariminia; E Bourreau; H Pascalis; P Couppié; D Sainte-Marie; F Tacchini-Cottier; P Launois
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.

Authors:  Henry W Murray; Kathleen C Flanders; Debra D Donaldson; Joseph P Sypek; Philip J Gotwals; Jianguo Liu; Xiaojing Ma
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

3.  Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27.

Authors:  Michaela Fakiola; E Nancy Miller; Manal Fadl; Hiba S Mohamed; Sarra E Jamieson; Richard W Francis; Heather J Cordell; Christopher S Peacock; Madhuri Raju; Eltahir A Khalil; Ahmed Elhassan; Ahmed M Musa; Fernando Silveira; Jeffrey J Shaw; Shyam Sundar; Selma M B Jeronimo; Muntaser E Ibrahim; Jenefer M Blackwell
Journal:  J Infect Dis       Date:  2011-08-01       Impact factor: 5.226

4.  Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function.

Authors:  Kevin J Esch; Rachel Juelsgaard; Pedro A Martinez; Douglas E Jones; Christine A Petersen
Journal:  J Immunol       Date:  2013-10-23       Impact factor: 5.422

5.  Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production.

Authors:  Nilufer B Norsworthy; Jiaren Sun; Dia Elnaiem; Gregory Lanzaro; Lynn Soong
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 6.  Eosinophils and mast cells in leishmaniasis.

Authors:  Nilda E Rodríguez; Mary E Wilson
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

7.  Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells.

Authors:  Simona Stäger; Asher Maroof; Soombul Zubairi; Stephanie L Sanos; Manfred Kopf; Paul M Kaye
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

8.  Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression.

Authors:  E Yaneth Osorio; Weiguo Zhao; Claudia Espitia; Omar Saldarriaga; Leo Hawel; Craig V Byus; Bruno L Travi; Peter C Melby
Journal:  PLoS Pathog       Date:  2012-01-19       Impact factor: 6.823

9.  Interleukin-12 is not essential for silicosis in mice.

Authors:  Gerald S Davis; Linda M Pfeiffer; David R Hemenway; Mercedes Rincon
Journal:  Part Fibre Toxicol       Date:  2006-01-05       Impact factor: 9.400

10.  The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes.

Authors:  Ioannis D Kyriazis; Olga S Koutsoni; Nektarios Aligiannis; Kalliopi Karampetsou; Alexios-Leandros Skaltsounis; Eleni Dotsika
Journal:  Parasit Vectors       Date:  2016-08-09       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.